Max Healthcare Institute (MAXHEALTH.NS) Stock Price
Max Healthcare Institute Price
Over the last 12 years Max Healthcare Institute grew revenue by 19.9% annually, reaching 83.73 B INR. Earnings per share have grown at 54.8% per year over the last 9 years. For Max Healthcare Institute, the net margin of 17.2% is up versus 15.4% a few years ago. At today's price the dividend yield works out to roughly 0.17%. The payout ratio is around 12% of earnings. The dividend has grown at 14.5% per year over the past 3 years. The consensus 12-month price target for Max Healthcare Institute is 1,295.40 INR, about 49.6% above where the stock trades today. Of 25 analysts, 18 rate the stock a buy — an overall Buy consensus.
Max Healthcare Institute stock price
Max Healthcare Institute business model & stock analysis
Frequently asked questions about Max Healthcare Institute
The main competitors of Max Healthcare Institute Ltd in the market are Apollo Hospitals, Fortis Healthcare, and Manipal Hospitals.
The business model of Max Healthcare Institute Ltd revolves around providing comprehensive healthcare services in India. As a leading healthcare organization, Max Healthcare operates a network of hospitals and medical centers that offer a wide range of clinical specialties and advanced treatments. The company focuses on delivering quality healthcare services through state-of-the-art infrastructure, highly skilled medical professionals, and advanced technology. Max Healthcare follows a patient-centric approach and aims to provide personalized care to individuals across all age groups. By prioritizing patient comfort, safety, and well-being, Max Healthcare strives to be a trusted and preferred healthcare provider in the country.
Max Healthcare Institute Ltd is primarily active in the healthcare industry.
Max Healthcare Institute Ltd is a leading healthcare provider in India. Established in 2000, the company has a rich history of delivering high-quality medical services to patients across the country. Max Healthcare Institute Ltd operates a network of hospitals and specialized centers, offering a comprehensive range of medical treatments and facilities. With a commitment to clinical excellence and patient-centric care, the company has emerged as a trusted name in the healthcare industry. Max Healthcare Institute Ltd continues to expand its footprint and invest in advanced technologies to provide the best possible healthcare solutions to its patients.
Max Healthcare Institute Ltd has achieved several significant milestones in its journey. It has emerged as one of India's leading healthcare providers, offering world-class medical services. The company has consistently expanded its network of hospitals and healthcare centers across various cities, providing accessible and quality healthcare to a larger population. Max Healthcare Institute Ltd has been recognized for its commitment to patient care and clinical excellence, receiving prestigious accreditations and certifications. Moreover, it has successfully introduced advanced medical technologies and treatments, ensuring cutting-edge and comprehensive healthcare services. It continues to strive towards innovation, patient-centricity, and delivering the highest standards of healthcare, further strengthening its position in the industry.
Max Healthcare Institute Ltd is primarily present in India.
Max Healthcare Institute Ltd represents a strong set of values and a unique corporate philosophy. As a leading healthcare provider, the company is committed to delivering global standards of medical expertise, patient-centric care, and innovative technology. Max Healthcare Institute Ltd strives to provide comprehensive healthcare solutions while maintaining the highest ethical standards and fostering a culture of empathy and compassion. With an unwavering focus on safety, integrity, and excellence, the company aims to enhance well-being and deliver superior healthcare services to its patients. Max Healthcare Institute Ltd prides itself on its dedication to quality, collaboration, and continuous improvement, making it a trusted name in the healthcare industry.
Analysts currently set an average price target of 1,244.12 INR for the Max Healthcare Institute stock (median: 1,295.40 INR), implying +43.7 % versus the latest price. The consensus is based on 25 analyst ratings.
26 analysts currently rate the Max Healthcare Institute stock: 19 recommend buying, 3 holding and 4 selling.
Converted at the current exchange rate, the Max Healthcare Institute share trades at 8.10 EUR (865.95 INR).
The Max Healthcare Institute share (MAXHEALTH.NS) is listed on 2 stock exchanges, including: NSE (Indien) (MAXHEALTH.NS).
Max Healthcare Institute Ltd is a leading healthcare company in India. The company operates in several divisions and offers a wide range of products and services to its customers. One of the main divisions of the company is the Max Hospitals Division, which operates 16 hospitals across India providing top-quality medical care in various specialties. Under the Max Labs Division, the company offers laboratory services including diagnostics and clinical tests. The Max Pharma Division is responsible for producing and distributing pharmaceutical products. The Max Clinics Division operates health centers and clinics offering various medical services. The Max Foundation is the company's social division, focused on improving healthcare in disadvantaged communities through free health camps and medical services. The company also provides health insurance and is involved in medical education and research. Overall, Max Healthcare Institute Ltd offers a wide range of products and services in the healthcare sector.
The revenue of Max Healthcare Institute is 83.73 B INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Max Healthcare Institute is 14.42 B INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Max Healthcare Institute is currently 58.67. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Max Healthcare Institute stock.
The price-to-sales ratio (P/S) of Max Healthcare Institute is currently 10.11. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Max Healthcare Institute stock.
The Eulerpool Quality Score for Max Healthcare Institute is 5/10.
The ISIN of Max Healthcare Institute is INE027H01010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Max Healthcare Institute is MAXHEALTH.NS. The ticker symbol is used to trade Max Healthcare Institute shares on the stock exchange.
Max Healthcare Institute stock
Max Healthcare Institute Peer Group
Max Healthcare Institute Ticker
Max Healthcare Institute FIGI
All fundamentals and in-depth analysis of Max Healthcare Institute
Our stock analysis for Max Healthcare Institute stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Max Healthcare Institute. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.